Skip to main content

CITADEL ADVISORS LLC

Position in AYTU — Aytu Biopharma, Inc

CIK 1423053 MIAMI, FL

Position in AYTU

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$106,240
+$5,665 QoQ
Shares Held
49,414
+34.1% QoQ
Ownership
0.460%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 38 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AYTU Over Time

Shares Held

Position Value (USD)

Derivatives in AYTU

reported options exposure · as of Sep 30, 2022
CallValue
$17,499
CallShares
4,605
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,675,844 across 65 Drug Manufacturers - Specialty & Generic names. AYTU ranks #50 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AYTU

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $106,240 49,414
2026-03-31 $100,575 36,841
2025-12-31 $40,432 15,551
2025-03-31 $36,591 30,493
2024-12-31 $18,805 11,062
2024-06-30 $63,685 21,810
2024-03-31 $37,012 12,175
2022-09-30 $17,499 92,100
2022-06-30 $101,775 147,500
2022-03-31 $97,632 90,400
2021-12-31 $150,255 111,300
2021-12-31 $132,470 98,127
2021-09-30 $42,912 14,900
2021-09-30 $109,670 38,080
2021-09-30 $252,198 87,569
2021-06-30 $122,138 24,379
2021-06-30 $141,783 28,300
2021-06-30 $184,368 36,800
2021-03-31 $188,183 24,761
2020-12-31 $500,382 83,676
2020-09-30 $13,429 11,285
2020-03-31 $62,310 41,540